Is Mochi Health Worth It? Pricing, Per-Dose Model, and Service Quality

Last reviewed: September 6, 2026 Last updated: September 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Mochi Health's per-dose pricing model creates a measurably lower entry cost—$99 per month total for compounded semaglutide at starting doses (combining a first-month introductory membership rate of $39 and $60 starting-dose medication cost; ongoing membership rate not documented) versus $189 month-to-month at PlexusDx—but the documented structure means maintenance costs rise as doses escalate, while PlexusDx holds the same price at every dose. Mochi's Trustpilot rating stands at 4.5 stars from approximately 18,000 reviews (captured September 4, 2026), higher than PlexusDx's 4.3-star rating (79% five-star, 83% four stars or higher), though negative review themes on Mochi's profile include individual reports of provider engagement and responsiveness issues. The economic case depends on whether you remain at starting doses—where Mochi's advantage is clear—or escalate to maintenance doses, where specific rates are not publicly documented and PlexusDx's flat pricing becomes a known quantity.

At-a-glance comparison

Normalized 12-month cost: the per-dose model's entry advantage and maintenance uncertainty

Mochi Health's per-dose pricing structure creates a clear cost advantage at starting doses, but the absence of publicly documented maintenance-dose rates makes long-term budgeting uncertain. Below we calculate 12-month totals under the assumption that a patient remains at starting doses and that Mochi's first-month $39 membership rate continues beyond the first month (neither assumption is confirmed by Mochi's published materials as of September 4, 2026). All derived figures are our calculation based on stated rates; readers should confirm current pricing and dose-escalation schedules at checkout.

Compounded semaglutide injection

Mochi Health (starting dose, IF first-month membership rate continues): Month 1 combines the introductory $39 membership and $60 starting-dose medication for $99 total; ongoing membership rate not documented. Months 2–12 repeat ($39 + $60) × 11 = $1,089 if the first-month rate holds. Twelve-month total: $1,188, or an effective monthly average of $99.00.

PlexusDx (month-to-month, same price every dose): $189/month × 12 = $2,268, or $189.00 per month effective. The prepaid six-month plan ($149/month prepaid) yields $1,788 over twelve months ($149 × 12 = our calculation), or $149.00 per month effective when prepaid.

Starting-dose price difference: Mochi's documented starting-dose structure is $1,080 lower over twelve months ($90 per month lower) than PlexusDx month-to-month, and $600 lower than PlexusDx's six-month prepaid plan. This advantage applies only if the patient remains at starting doses; Mochi's per-dose model means costs rise with dose escalation to levels not publicly documented.

Compounded tirzepatide injection

Mochi Health (starting dose, IF first-month membership rate continues): Month 1: introductory $39 membership + $90 medication = $129; ongoing membership rate not documented. Months 2–12: ($39 + $90) × 11 = $1,419 if the first-month rate holds. Twelve-month total: $1,548, or $129.00 per month effective.

PlexusDx (month-to-month, same price every dose): $289/month × 12 = $3,468, or $289.00 per month effective. The prepaid six-month plan ($249/month prepaid) yields $2,988 over twelve months ($249 × 12 = our calculation), or $249.00 per month effective when prepaid.

Starting-dose price difference: Mochi's starting-dose structure is $1,920 lower over twelve months ($160 per month lower) than PlexusDx month-to-month, and $1,440 lower than the six-month prepaid plan, again with the caveat that maintenance-dose costs are unknown.

Critical pricing limitations: Mochi's documented advantage applies only at starting doses. The per-dose model means maintenance-dose costs will exceed the $60/$90 starting rates, but specific escalation tiers are not published. PlexusDx's flat pricing structure means $189/$289 holds at every dose, making long-term budgeting straightforward. Readers escalating doses should request Mochi's maintenance-dose pricing before committing.

Service quality and review record: what patients report

Mochi Health holds a 4.5-star rating on Trustpilot from approximately 18,000 reviews (captured September 4, 2026), a higher aggregate score than PlexusDx's 4.3-star rating (79% five-star, 83% four stars or higher, captured September 9, 2026). The larger review volume and higher average suggest broad satisfaction across Mochi's patient base.

Negative review themes on Mochi's Trustpilot profile include individual reports of providers appearing late to video visits or not engaging substantively during consultations. One captured example describes a provider joining a video call behind schedule and offering minimal interaction. These are individual allegations and paraphrases of reported experiences; they may not represent typical outcomes, but they appear with enough frequency in the one- and two-star pass to warrant attention for patients prioritizing responsive provider communication.

Reddit search results captured on September 4, 2026, included anecdotes about shipping delays. Reddit reports are unverified, lack clinical or commercial context, and should not be treated as established facts. We note them because shipping reliability affects medication continuity, but isolated forum complaints do not establish a pattern.

PlexusDx's review profile is smaller by volume but shows strong positive clustering at four and five stars. Standard telemedicine friction themes—intake questions, eligibility criteria, and asynchronous communication—appear in negative reviews, but no systematic service-failure pattern emerges.

Decision factors: when per-dose pricing works and when flat pricing protects

Mochi Health's structural strengths

• Lower entry cost at starting doses: The documented $60/$90 medication rates combined with a first-month introductory $39 membership (ongoing rate not documented) create a $99–129 all-in starting point, measurably below PlexusDx's $189/$289 flat rates and competitive with other per-dose models.
• Higher aggregate review rating: The 4.5-star Trustpilot average from ~18,000 reviews reflects broad patient satisfaction and a larger evidence base than most telemedicine competitors.
• Branded medication pathway: Mochi offers branded GLP-1 options in addition to compounded formulations, though pricing for branded prescriptions is not documented in public sources.

Mochi Health's documented gaps

• Maintenance-dose pricing unknown: The per-dose model explicitly states that higher doses cost more, but specific rates for maintenance tiers are not published. Patients escalating doses cannot budget accurately without requesting a full fee schedule.
• Ongoing membership rate ambiguous: Mochi's website states "$39 first month" membership but does not document whether that rate continues or increases after month one, creating uncertainty in long-term cost projections.
• Provider engagement themes in negative reviews: Individual Trustpilot reports describe late or disengaged provider visits. These are anecdotal and may not be typical, but they appear in the negative-review pass frequently enough to note for patients who value structured, engaged clinical consultations.
• Separate membership and medication charges: The two-line billing structure (membership + medication) adds administrative complexity compared to all-inclusive pricing.

PlexusDx's structural strengths

• Flat pricing across all doses: $189 semaglutide and $289 tirzepatide hold at starting, escalation, and maintenance doses, eliminating budgeting uncertainty and per-dose cost increases.
• No separate membership fee: One monthly charge covers provider visit, prescription, compounded medication, and shipping—no layered billing.
• Prepaid discount tiers: Three-month and six-month prepaid plans reduce per-month cost ($149 semaglutide, $249 tirzepatide at six months) for patients confident in long-term use.
• Transparent dose policy: Same-price-every-dose structure is stated clearly on product pages and upheld in customer-reported experiences.

PlexusDx's documented gaps

• Higher entry cost: $189/$289 month-to-month rates are $90–160 higher per month than Mochi's documented starting-dose structure, a meaningful gap for patients beginning treatment.
• Smaller review volume: PlexusDx's Trustpilot profile, while strongly rated at 4.3 stars with 83% four stars or higher, reflects a smaller patient base than Mochi's ~18,000-review sample.

Choose Mochi Health if…

You are beginning GLP-1 therapy, expect to remain at or near starting doses, and prioritize the lowest possible monthly outlay. The documented $99–129 all-in starting rate (assuming the first-month introductory membership rate continues; ongoing rate not documented) is competitive with any telemedicine program reviewed to date. The 4.5-star Trustpilot rating and 18,000-review volume suggest broad patient satisfaction. Request Mochi's full dose-escalation fee schedule before committing if you anticipate moving to maintenance doses, and confirm whether the first-month membership rate continues beyond month one. If you value responsive, engaged provider consultations, review the negative-theme examples on Trustpilot to calibrate expectations.

Choose PlexusDx if…

You are escalating doses or entering maintenance and want cost certainty throughout treatment. PlexusDx's flat $189/$289 pricing means no per-dose increases, no separate membership line, and no ambiguity in long-term budgeting. The all-inclusive structure—provider visit, prescription, compounded medication, and shipping in one monthly charge—simplifies billing and eliminates layered fees. The prepaid six-month tier ($149 semaglutide, $249 tirzepatide) narrows the gap against Mochi's starting-dose rates while preserving flat pricing. If you prioritize transparent dose policies and are willing to pay a higher entry rate for long-term predictability, PlexusDx's model protects against escalation surprises.

Methodology and freshness

All pricing, service-structure, and review-rating data were captured on September 4, 2026, from Mochi Health's public website (joinmochi.com/blog/per-dose-pricing-mochi-health and joinmochi.com/medications/compounded-tirzepatide) and Trustpilot profiles for both Mochi Health and PlexusDx. Mochi's $39 membership figure is labeled "first month" in source materials; the ongoing rate after month one is not documented. Mochi's $60 semaglutide and $90 tirzepatide figures apply to starting doses; the per-dose model means higher doses cost more, but specific maintenance rates are not published. Twelve-month cost totals, effective monthly averages, and price-difference calculations are our own work, derived from the captured rates under the stated assumptions. Review themes are paraphrased from individual Trustpilot reports captured on September 4, 2026; they are anecdotes and allegations, not verified facts. Reddit mentions are included for context but are unverified and may not represent typical patient experiences. PlexusDx pricing reflects the company's published month-to-month, three-month, and six-month rate cards. Readers should confirm all figures, dose-escalation schedules, membership terms, and eligibility criteria at checkout before committing to either program.

Frequently Asked Questions

Does Mochi Health's first-month membership rate continue after month one?

Mochi Health's website states "$39 first month" membership but does not document the ongoing rate beyond month one as of September 4, 2026. Contact Mochi directly to confirm whether the first-month rate holds or increases, and factor that into your 12-month budget if you plan long-term treatment.

How much does Mochi Health charge for maintenance doses of semaglutide and tirzepatide?

Mochi operates a per-dose pricing model where higher doses cost more than the documented $60 semaglutide and $90 tirzepatide starting rates. Specific maintenance-dose pricing is not published on their website. Request a full fee schedule during intake or from customer support before committing if you expect dose escalation.

Does PlexusDx charge more when I increase my dose?

No. PlexusDx holds the same monthly price at every dose: $189 for compounded semaglutide injection and $289 for compounded tirzepatide injection on the month-to-month plan, with lower per-month rates on prepaid three-month and six-month commitments. Dose escalation does not trigger a price increase.

What do Mochi Health's negative reviews say?

Individual Trustpilot reports describe providers appearing late to video consultations or offering minimal engagement during visits. These are anecdotal accounts captured from the one- and two-star review pass on September 4, 2026. They may not represent typical experiences, but they appear frequently enough in the negative slice to note for patients who prioritize responsive clinical communication.

Can I switch from Mochi Health to PlexusDx or vice versa?

Transferring between telemedicine providers requires a new intake, prescription, and pharmacy arrangement. Neither Mochi nor PlexusDx guarantees continuity of the same compound formulation, dose, or delivery schedule when switching. Expect a clinical review, possible dose adjustment, and at least one billing cycle of overlap or gap. Plan switches during stable treatment phases, not during active dose escalation.

Sources

• PlexusDx. Pricing and service-structure details. Product pages and internal rate cards. Accessed July 17–23, 2026, and verified September 4, 2026.
• Mochi Health. "Per-Dose Pricing at Mochi Health." https://joinmochi.com/blog/per-dose-pricing-mochi-health. Accessed September 4, 2026.
• Mochi Health. "Compounded Tirzepatide." https://joinmochi.com/medications/compounded-tirzepatide. Accessed September 4, 2026.
• Trustpilot. Mochi Health and PlexusDx company profiles, aggregate ratings, and review samples. Captured September 4, 2026.
• Reddit. Anecdotal mentions of Mochi Health shipping experiences. Search captured September 4, 2026. Unverified; included for context only.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.